ADC Therapeutics SA Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
ADC Therapeutics SA (ADCT) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $2.39 per share for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2023-11-07
- ADC Therapeutics SA weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2023-03-31 was $2.50, a 82.63% decline year-over-year.
- ADC Therapeutics SA weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2022-03-31 was $14.39, a 50.24% decline year-over-year.
- ADC Therapeutics SA weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2021-03-31 was $28.92.
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 3 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 9 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.39 6-K · filed 2023-11-07 | |||
| 2023-06-30 | $2.47 6-K · filed 2023-08-08 | |||
| 2023-03-31 | $2.50 6-K · filed 2023-05-09 | |||
| 2022-12-31 | $9.63 20-F · filed 2023-03-15 | |||
| 2022-09-30 | $12.26 6-K · filed 2022-11-08 | |||
| 2022-06-30 | $13.11 6-K · filed 2022-08-09 | |||
| 2022-03-31 | $14.39 6-K · filed 2022-05-09 | |||
| 2021-12-31 | $28.22 20-F · filed 2023-03-15 | |||
| 2021-09-30 | $28.33 6-K · filed 2021-11-02 | |||
| 2021-06-30 | $28.66 6-K · filed 2021-08-03 | |||
| 2021-03-31 | $28.92 6-K · filed 2021-05-06 | |||
| 2020-12-31 | $28.62 20-F · filed 2023-03-15 | |||
| 2019-12-31 | $18.75 20-F · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |